Pediatric pituitary adenomas in Northeast Mexico. A follow-up study

Endocrine
Lucia Torres-GarcíaMarcela Márquez

Abstract

To review incidence, treatment and outcome of pediatric pituitary adenomas (PAs). A follow-up study patients with the age of ≤19 years old who were treated from 1995 to 2015 in Mexico. Out of 1244 diagnosed PA, 43 patients were children (35 females, 8 males) with a mean age of 17.2 years. The majority were macroadenomas (70%) with prolactinomas (PRL) dominating (63%) followed by non-functioning adenomas (21%). In total, 40% were diagnosed as invasive. Growth hormone (GH) secreting adenomas, adrenocorticotropic hormone secreting and mixed GH-PRL secreting were rare. The treatment modalities were dopamine agonists and surgery. The average treatment time was 44 months with an average follow-up period of 104 months. Sixty-eight percent (27/40) of the patients had complete response after long time follow-up. Thirty-one percent did not respond to treatment whereof three patients died due to advanced disease and late intervention. The principal causes for treatment failure were treatment resistance, late intervention and poor patient compliance. Sixty eight percent had complete treatment response without any sign of disease, while ~31% did not respond to treatment or did not comply to follow up/treatment. Optimized early diagnose, tre...Continue Reading

References

Apr 1, 1985·The Journal of Clinical Endocrinology and Metabolism·M E MolitchM O Thorner
May 1, 1984·Annals of Surgery·C G ThomasF B Askin
Apr 1, 1995·Journal of Pediatric Endocrinology & Metabolism : JPEM·T Mindermann, C B Wilson
Feb 1, 1995·Neurosurgery·T Mindermann, C B Wilson
Feb 1, 1994·Journal of Neurosurgery·M D PartingtonB W Scheithauer
Aug 26, 1998·The Journal of Clinical Endocrinology and Metabolism·A ColaoG Lombardi
Dec 22, 1999·The Journal of Clinical Endocrinology and Metabolism·A R Lafferty, G P Chrousos
Dec 22, 1999·The Journal of Clinical Endocrinology and Metabolism·S Kunwar, C B Wilson
Mar 19, 2003·Clinical Endocrinology·S CannavòF Trimarchi
Aug 4, 2005·Indian Journal of Pediatrics·S K Singh, Rohit Aggarwal
Aug 5, 2006·Clinical Endocrinology·Felipe F CasanuevaAndrea Giustina
Dec 5, 2006·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·M Mehrazin
Aug 8, 2007·The Journal of Clinical Endocrinology and Metabolism·Janet A Schlechte
Oct 30, 2007·Neurologic Clinics·Jay JagannathanEdward R Laws
Apr 18, 2008·Expert Review of Neurotherapeutics·Margaret F Keil, Constantine A Stratakis
Oct 24, 2008·Pituitary·Shrikrishna V AcharyaNalini S Shah
Sep 30, 2009·Hormone Research·H L FideleffM Azaretzky
Dec 4, 2009·Endocrine Development·Annamaria Colao, Sandro Loche
Dec 14, 2011·Current Opinion in Endocrinology, Diabetes, and Obesity·Molly H Harrington, Samuel J Casella
Feb 15, 2014·Hormone Research in Pædiatrics·Federica GuaraldiMartin O Savage
Jan 13, 2015·Neuroendocrinology·Eleftherios ChatzellisGregory Kaltsas
Feb 9, 2017·JAMA : the Journal of the American Medical Association·Mark E Molitch

❮ Previous
Next ❯

Software Mentioned

nQuery Advisor
SPSS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.